ARLINGTON, Va., Feb. 08, 2017 -- Leading healthcare social network Inspire has reached the milestone of one million registered members.
“It’s gratifying and humbling to see the community’s growth,” said Brian Loew, co-founder and CEO of Inspire. “We see it as a testament to the wisdom of empowered patients and caregivers who are leading a movement toward patient-centered care.”
Inspire is known for not just the size of the community but for the activity of the patients and caregivers interacting in more than 200 online groups. Last year, Inspire reached another milestone of one billion words written by its community members.
“The rate at which members are finding and joining Inspire is accelerating exponentially,” said Richard Tsai, VP of marketing at Inspire. “Patients and caregivers across several thousand reported conditions are writing about their experiences, and generating relevant language that others who are facing similar experience can find.”
This sharing of information can be particularly useful for rare disease patients who often have trouble getting an accurate diagnosis, and for cancer patients who are in dire need of support to make the best possible treatment decisions.
Loew noted that Inspire is adding more communities and nonprofit partners regularly. “While we have more improvements planned for our online platform,” he added, “we are committed to ensuring that the focus will continue to be on the wonderful patients and caregivers who share and connect with each other every day in our community.”
About Inspire
Inspire (www.inspire.com) is the patient engagement company. Founded in 2005, Inspire creates and manages health support communities in partnership with over 100 nonprofit organizations, including the American Lung Association, National Psoriasis Foundation, Ovarian Cancer Research Fund Alliance, the Arthritis Foundation, and the Alzheimer's Foundation of America. Inspire works with its pharmaceutical clients to help them explore engagement and insight opportunities with these highly engaged populations of patients. Inspire helps companies integrate patient-centricity into the pharmaceutical product lifecycle, from clinical trial design and recruitment to post-marketing brand/unbranded activities.
Contact: John Novack Inspire (800) 945-0381 [email protected]


California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Italy Fines Apple €98.6 Million Over App Store Dominance
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 



